Psychopharmacological treatment of mood and anxiety disorders during pregnancy

Handbook of Experimental Pharmacology

Volumn 214, Issue , 2012, Pages 279-305

  Krüger, Stephanie ^a  

^a VIVANTES HOSPITAL   (Germany)

Author keywords

Antidepressants; Antipsychotics; Benzodiazepines and mood stabilisers; Pregnancy

Indexed keywords

AGOMELATINE; AMFEBUTAMONE; AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; BUTYROPHENONE DERIVATIVE; CARBAMAZEPINE; CLOZAPINE; DIAZEPAM; FOLIC ACID; LAMOTRIGINE; LITHIUM; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; PAROXETINE; PREGABALIN; PSYCHOTROPIC AGENT; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; VENLAFAXINE;

ANXIETY DISORDER; ARTICLE; CHILD BEHAVIOR; CONGENITAL MALFORMATION; DEVELOPMENTAL STAGE; DRUG APPROVAL; DRUG INDICATION; DRUG METABOLISM; HIGH RISK PREGNANCY; HUMAN; MENTAL DISEASE; MOOD DISORDER; NEUROTOXICITY; NEWBORN DISEASE; NONHUMAN; PERSISTENT PULMONARY HYPERTENSION; PLACENTAL TRANSFER; PREGNANCY DISORDER; PREMATURE LABOR; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; PSYCHOPHARMACOTHERAPY; RECOMMENDED DRUG DOSE; REPRODUCTIVE TOXICITY; RISK BENEFIT ANALYSIS; RISK REDUCTION; SPINAL DYSRAPHISM; TERATOGENICITY; DRUG EFFECT; FEMALE; FETUS; PREGNANCY; PREGNANCY COMPLICATION; REVIEW;

ABNORMALITIES, DRUG-INDUCED; ANXIETY DISORDERS; FEMALE; FETUS; HUMANS; MOOD DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS; PSYCHOTROPIC DRUGS;

EID: 84868335372     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/978-3-642-30726-3_14     Document Type: Article

References (184)

1. Alwan S, Reefhuis J, Rasmussen SA (2007) Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med 356:2684-2692
2. American Medical Association (AMA), Drug interactions and adverse drug reactions. In: AMA Drug Evaluations, AMA, Chicago; pp: 31-44, 1983.
3. Ananth J (1976) Side effects on fetus and infant of psychotropic drug use during pregnancy. Int Pharmacopsychiatry 11:246-260
4. Arora M, Praharaj SK (2006) Meningocele and ankyloblepharon following in utero exposure to olanzapine. Eur Psychiatry 21:341-346
5. Artama M, Ritvanen A, Gissler M, Isojärvi J, Auvinen A (2005) Congenital structural anomalies in offspring of women with epilepsy - a population-based cohort study in Finland. Int J Epidemiol 35(2):280-287
6. Bardy AH, Lillsunde P, Hiilesmaa VK, Seppälä T (1994) Objectively measured perinatal exposure to meperidine and benzodiazepines in Finland. Clin Pharmacol Ther 55(4):471-476
7. Barnas C, Bergant A, Hummer M, Saria A, Fleischhacker WW (1994) Clozapine concentrations in maternal and fetal plasma, amniotic fluid, and breast milk [letter]. Am J Psychiatry 151:945
8. Bar-Oz B, Einarson T, Einarson A (2007) Paroxetine and congenital malformations: meta-analysis and consideration of potential confounding factors. Clin Ther 29:918-926
9. Barr JA, Beck CT (2008) Infanticide secrets: qualitative study on postpartum depression. Can Fam Physician 54(12):1716-1717.e5
10. Birnbaum CS, Cohen LS, Bailey JW, Grush LR, Robertson LM, Stowe ZN (1999) Serum concentrations of antidepressants and benzodiazepines in nursing infants: a case series. Pediatrics 104(1):e 111
11. Biswas PN, Wilton LV, Pearce GL, Freehahtle S, Shakir SA (2001) The pharmacovigilance of olanzapine: results of a post-marketing surveillance study on 8858 patients in England. J Psychopharmacol 15:265-271
12. Bromley RL, Baker GA, Meador KJ (2009) Cognitive abilities and behaviour of children exposed to antiepileptic drugs in utero. Curr Opin Neurol 22(2):162-166
13. Cabuk D, Sayin A, Derinöz O, Biri A (2007) Quetiapine use for the treatment of manic episode during pregnancy. Arch Womens Ment Health 10:235-236, 86
14. Cattaruzza MS, Spinelli A (2000) Spontaneous abortion in Italy: social differences and temporal trends. Epidemiol Prev 24(4):166-171
15. Chambers C (2012) Prenatal alcohol exposure patterns and alcohol-related birth defects and growth deficiencies: a prospective study. Alcohol Clin Exp Res 168(11):1179-1185, 1
16. Chambers CD, Johnson KA, Dick LM, Felix RJ, Jones KL (1996) Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 335(14):1010-1015
17. Chambers CD, Hernandez-Diaz S, van Marter LJ et al (2006) Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 354(6):579-587
18. Charlton RA, Weil JG, Cunnington MC, Ray S, de Vries CS (2011) Comparing the General Practice Research Database and the UK Epilepsy and Pregnancy Register as tools for postmarketing teratogen surveillance: anticonvulsants and the risk of major congenital malformations. Drug Saf 34(2):157-171
19. Cohen LS, Friedman JM, Jefferson JW, Johnson EM, Weiner ML (1994) A reevaluation of risk of in utero exposure to lithium. JAMA 271:146-150
20. Cohen MJ, Meador KJ, Browning N, Baker GA, Clayton-Smith J, Kalayjian LA, Kanner A, Balke LD (2001). Quetiapine is effective in the treatment of bipolar affective disorder during pregnancy. Poster session presented at: 7th World Congress of Biological Psychiatry; July 1-6. Berlin, Germany
21. Coppola D, Russo LJ, Kwarta RF Jr, Varughese S, Schmider J (2007) Evaluating the postmarketing experience of risperidone use during pregnancy. Pregnancy and neonatal outcomes. Drug Saf 30:247-264
22. Costei AM, Kozer E, Ho T, Ito S, Koren G (2002) Perinatal outcome following third trimester exposure to paroxetine. Arch Pediatr Adolesc Med 156(11):1129-1132
23. Craig JJ, Gray WJ, McCann JP (1999) The Chiari/hydrosyringomyelia complex presenting in adults with myelomeningocoele: an indication for early intervention. Spinal Cord 37(4):275-278
24. Cummings C, Stewart M, Stevenson M, Morrow J, Nelson J (2011) Neurodevelopment of children exposed in utero to lamotrigine, sodium valproate and carbamazepine. Arch Dis Child 96(7):643-647
25. Cunnington MC, Tennis P, Committee ILPRSA (2005) Lamotrigine and the risk of malformations in pregnancy. Neurology 64:955-960
26. Cunnington MC, Weil JG, Messenheimer JA, Ferber S, Yerby M, Tennis P (2011) Final results from 18 years of the International Lamotrigine Pregnancy Registry. Neurology 76(21):1817-1823
27. Cunnington MC, Weil JG, Messenheimer JA, Ferber S, Yerby M, Tennis P (2011) Neurology. 76(21):1817-1823
28. Cupit GC, Rotmensch HH (1985) Principles of drug therapy in pregnancy. In: Gleicher N (ed) Principles of medical therapy in pregnancy. Plenum Press, New York, pp 77-90
29. Czeizel AE (2011) Periconceptional folic acid-containing multivitamin supplementation for the preventionofneural tube defects and cardiovascular malformations. Ann Nutr Metab 59(1):38-40
30. Dalmizrak O, Kulaksiz-Erkmen G, Ozer N (2011) The inhibition characteristics of human placental glutathione S-transferase-p by tricyclic antidepressants: amitriptyline and clomipramine. Mol Cell Biochem 355(1-2):223-231
31. De Santis M, De Luca C, Mappa I, Cesari E, Quattrocchi T, Spagnuolo T, Visconti D, Caruso A (2011) Antiepileptic drugs during pregnancy: pharmacokinetics and transplacental transfer. Curr Pharm Biotechnol 12(5):781-788, Review
32. De Wals P, Tairou F, Van Allen MI, Uh SH, Lowry RB, Sibbald B, Evans JA, Van den Hof MC, Zimmer P, Crowley M, Fernandez B, Lee NS, Niyonsenga T (2007) Reduction in neural-tube defects after folic acid fortification in Canada. N Engl J Med 357(2):135-142
33. De Wals P, Van Allen MI, Lowry RB, Evans JA, Van den Hof MC, Crowley M, Tairou F, Uh SH, Sibbald B, Zimmer P, Fernandez B, Lee NS, Niyonsenga T (2008a) Impact of folic acid food fortification on the birth prevalence of lipomyelomeningocele in Canada. Birth Defects Res A Clin Mol Teratol 82(2):106-109
34. De Wals P, Tairou F, Van Allen MI, Lowry RB, Evans JA, Van den Hof MC, Crowley M, Uh SH, Zimmer P, Sibbald B, Fernandez B, Lee NS, Niyonsenga T (2008b) Spina bifida before and after folic acid fortification in Canada. Birth Defects Res A Clin Mol Teratol 82(9):622-626
35. Di Michele V, Ramenghi LA, Sabatino G (1996) Clozapine and lorazepam administration in pregnancy [letter]. Eur Psychiatry 11:214
36. Diav-Citrin O, Ornoy A (2012). Selective serotonin reuptake inhibitors in human pregnancy: to treat or not to treat? Obstet Gynecol Int. (epub ahead of print)
37. Diav-Citrin O, Shechtman S, Ornoy S et al (2005) Safety of haloperidol and penfluridol in pregnancy: a multicenter, prospective, controlled study. J Clin Psychiatry 66:317-322
38. Diav-Citrin O, Shechtman S, Weinbaum D (2008) Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study. Br J Clin Pharmacol 66(5):695-705
39. Duran A, Ugur MM, Turan S, Emuk M (2008) Clozapine use in two women with schizophrenia during pregnancy. J Psychopharmacol 22:111-113
40. Einarson TR, Einarson A (2005) Newer antidepressants in pregnancy and rates of major malformations: a meta-analysis of prospective comparative studies. Pharmacoepidemiol Drug Saf 14:823-827
41. Einarson A, Pistelli A, DeSantis M (2008) Evaluation of the risk of congential cardiovascular defects associated with use of paroxetine during pregnancy. Am J Psychiatry 165:749-752
42. Ericson A, Kallen B, Wiholm BE (1999) Delivery outcome after the use of antidepressants in early pregnancy. Eur J Clin Pharmacol 55:503-508
43. Frey B, Schubiger G, Musy J (1990) Transient cholestatic hepatitis in a neonate associated with carbamazepine exposure during pregnancy and breastfeeding. Eur J Pediatr 150:136-138
44. Gentile S (2006) Quetiapine-fluvoxamine combination during pregnancy and while breastfeeding [letter]. Arch Womens Ment Health 9:158-159
45. Gentile S (2010) Antipsychotic therapy during early and late pregnancy: a systematic review. Schizophr Bull 36(3):518-544
46. Gentile S, Tofani S, Bellantuono C (2011) Aripiprazole and pregnancy: a case report and literature review. J Clin Psychopharmacol 31(4):531-532, Review
47. Gidai J, Acs N, Bánhidy F, Czeizel AE (2008a) No association found between use of very large doses of diazepam by 112 pregnant women for a suicide attempt and congenital abnormalities in their offspring. Toxicol Ind Health 24(1-2):29-39
48. Gidai J, Acs N, Bánhidy F, Czeizel AE (2008b) An evaluation of data for 10 children born to mothers who attempted suicide by taking large doses of alprazolam during pregnancy. Toxicol Ind Health 24(1-2):53-60
49. Gidai J, Acs N, Bánhidy F, Czeizel AE (2008c) A study of the effects of large doses of medazepam used for self-poisoning in 10 pregnant women on fetal development. Toxicol Ind Health 24(1-2):61-68
50. Godet PF, Marie-Cardine M (1991) Neuroleptics, schizophrenia, and pregnancy. Epidemiological and teratologic study. Encéphale 7:543-547
51. Goldstein DJ, Corbin LA, Sundell KL (1997) Effects of first-trimester fluoxetine exposure on the newborn. Obstet Gynecol 89:713-718
52. Goldstein DJ, Corbis LA, Fung MC (2000) Olanzapine-exposed pregnancies and lactation: early experience. J Clin Psychopharmacol 20:399-403
53. Grover S, Gupta N (2005) Lithium associated anencephaly. Can J Psychiatry 50:185-186
54. Grover S, Avasthi A, Sharma Y (2006) Psychotropics in pregnancy: weighing the risks. Indian J Med Res 123:497-512
55. Gupta N, Grover S (2004) Safety of clozapine in 2 successive pregnancies [letter]. Can J Psychiatry 49:863
56. Hanson JW, Oakley GP (1975) Haloperidol and limb deformity [letter]. JAMA 321:26
57. Harden CL, Meador KJ, Pennell PB, Hauser WA, Gronseth GS, French JA, Wiebe S, Thurman D, Koppel BS, Kaplan PW, Robinson JN, Hopp J, Ting TY, Gidal B, Hovinga CA, Wilner AN, Vazquez B, Holmes L, Krumholz A, Finnell R, Hirtz D, Le Guen C (2009a) American Academy of Neurology; American Epilepsy Society. Epilepsia 50(5):1237-1246, Review
58. Harden CL, Meador KJ, Pennell PB, Hauser WA, Gronseth GS, French JA, Wiebe S, Thurman D, Koppel BS, Kaplan PW, Robinson JN, Hopp J, Ting TY, Gidal B, Hovinga CA, Wilner AN, Vazquez B, Holmes L, Krumholz A, Finnell R, Hirtz D, Hirtz D, Le Guen C, American Academy of Neurology; American Epilepsy Society (2009) Practice parameter update: management issues for women with epilepsy-focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society. Neurology 73(2):133-141
59. Harden CL, Meador KJ, Pennell PB, Hauser WA, Gronseth GS, French JA, Wiebe S, Thurman D, Koppel BS, Kaplan PW, Robinson JN, Hopp J, Ting TY, Gidal B, Hovinga CA, Wilner AN, Vazquez B, Holmes L, Krumholz A, Finnell R, Hirtz D, Le Guen C (2009c) American Academy of Neurology; American Epilepsy Society. Neurology. 73(2):133-141
60. Hendrick V, Smith LM, Suri R (2003) Birth outcomes after prenatal exposure to antidepressant medication. Am J Obstet Gynecol 188:812-815
61. Holmes LB, Mittendorf R, Shen A, Smith CR, Hernandez-Diaz S (2011) Fetal effects of anticonvulsant polytherapies: different risks from different drug combinations. Arch Neurol 68(10):1275-1281
62. Hudak ML, Tan RC (2012) The Committee on drugs: the committee on fetus and newborn. Neonatal Drug Withdrawal. Pediatrics 129(2):540-560
63. Jacobson SJ, Jones K, Johnson K, Ceolin L, Kaur P, Sahn D et al (1992) Prospective multicentric study of pregnancy outcome after lithium exposure during first trimester. Lancet 339:530-533
64. Risperdal (risperidone) Janssen, LP prescribing information. Accessed December 1, 2005.
65. Jentink J, Loane MA, Morris JK, Wellesley D, Garne E, de Jong-van den Berg L, for the EUROCAT Antiepileptic Study Working Group (2010a) Intrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-control study. BMJ 341:581-609, Review
66. Jentink J, Loane MA, Dolk H, Barisic I, Garne E, Morris JK, den Berg LT De Jong-van, EUROCAT Antiepileptic Study Working Group (2010b) Valproic acid monotherapy in pregnancy and major congenital malformations. N Engl J Med 362(23):2185-2193, Review
67. Källén B (2004) Neonate characteristics after maternal use of antidepressants in late pregnancy. Arch Pediatr Adolesc Med 158(4):312-316
68. Källén B, Otterblad-Olausson P (2008) Maternal use of selective serotonin re-uptake inhibitors and persistent pulmonary hypertension of the newborn. Pharmacoepidemiol Drug Saf 17(8):801-806
69. Kantola-Sorsa E, Gaily E, Isoaho M, Korkman M (2007) Neuropsychological outcomes in children of mothers with epilepsy. J Int Neuropsychol Soc 13(4):642-652
70. Karakula H, Szajer K, Śpila B, Gryza A, Guy A, Przywara G (2004) Clozapine and pregnancy. A case history. Pharmacopsychiatry 37:303-304
71. Kauppi A, Kumpulainen K, Vanamo T, Merikanto J, Karkola K (2008) Maternal depression and filicide-case study of ten mothers. Arch Womens Ment Health 11(3):201-206
72. Kauppi A, Kumpulainen K, Karkola K, Vanamo T, Merikanto J (2010) Maternal and paternal filicides: a retrospective review of filicides in Finland. J Am Acad Psychiatry Law 38(2):229-238
73. Klier CM, Mossaheb N, Saria A, Schloegelhofer M, Zernig G (2007) Pharmacokinetics and elimination of quetiapine, venlafaxine, and trazodone during pregnancy and postpartum. J Clin Psychopharmacol 27(6):720-722
74. Klys M, Rojek S, Rzepecka-Woźniak E (2007) Neonatal death following clozapine self-poisoning in late pregnancy. An unusual case-report. Forensic Sci Int 171:e5-e10
75. Kopelman R, Stuart S (2005) Psychological treatments for postpartum depression. Psychiatr Ann 35:556-566
76. Kruninger U, Meltzer V, Hiemke C, Herpich S (2007) Pregnancy and lactation under treatment with quetiapine. Psychiatr Prax 34(suppl):75-76
77. Kulaga S, Sheehy O, Zargarzadeh AH, Moussally K, Bérard A (2011) Antiepileptic drug use during pregnancy: perinatal outcomes. Seizure 20(9):667-672
78. Kulin NA, Pastuszak A, Sage SR et al (1998a) Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study. JAMA 279:609-610
79. Kulin NA, Pastuszak A, Sage SR (1998b) Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study. JAMA 279(8):609-610
80. Laegreid L, Hagberg G, Lundberg A (1992) The effect of benzodiazepines on the fetus and the newborn. Neuropediatrics 23(1):18-23
81. Leppée M, Culig J, Eric M, Sijanovic S (2010) The effects of benzodiazepines in pregnancy. Acta Neurol Belg 110(2):163-167
82. Levinson-Castiel R, Merlob P, Linder N (2006) Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants. Arch Pediatr Adolesc Med 160:173-176
83. Liporace JD, Pennell PB, Privitera M, Loring DW (2011a) NEAD Study Group. Foetal antiepileptic drug exposure and verbal versus non-verbal abilities at three years of age. Brain 134(Pt 2):396-404
84. Liporace JD, Pennell PB, Privitera M, Loring DW (2011b) Fetal antiepileptic drug exposure: motor, adaptive, and emotional/behavioral functioning at age 3 years. Epilepsy Behav 22(2):240-246
85. Livezey GT, Rayburn WF (1992) Principles of perinatal pharmacology. In: Rayburn WF, Zuspann FP (eds) Drug therapy in obstetrics and gynecology, 3rd edn. St. Louis, Mosby-Year Book, Inc, pp 12-1992
86. Llewellyn A, Stowe Z, Strader JR (1998) The use of lithium and management of women with bipolar disorder during pregnancy and lactation. J Clin Psychiatry 59(Suppl 6):57-64
87. Louik C, Lin AE, Werler MM (2007) First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. N Engl J Med 356:2675-2683
88. Lutz UC, Hiemke C, Wiatr G, Farger G, Arand J, Wildgruber D (2010) Aripiprazole in pregnancy and lactation: a case report. J Clin Psychopharmacol 30(2):204-205
89. Madadi P, Ito S (2010) Perinatal exposure to maternal lamotrigine: clinical considerations for the mother and child. Can Fam Physician 56(11):1132-1134
90. Malm H, Klaukka T, Neuvonen PJ (2005) Risks associated with selective serotonin reuptake inhibitors in pregnancy. Obstet Gynecol 106(6):1289-1296
91. Marinucci L, Balloni S, Carinci F, Locci P, Pezzetti F, Bodo M (2011) Diazepam effects on non-syndromic cleft lip with or without palate: epidemiological studies, clinical findings, genes and extracellular matrix. Expert Opin Drug Saf 10(1):23-33, Review
92. McElhatton PR (1994) The effects of benzodiazepine use during pregnancy and lactation. Reprod Toxicol 8(6):461-475
93. McElhatton PR, Garbis HM, Elefant E (1996) The outcome of pregnancy in 689 women exposed to therapeutic doses of antidepressants. A collaborative study of the European Network of Teratology Information Services (ENTIS). Reprod Toxicol 10:285-294
94. McKenna K, Koren G, Tetelbaum M (2005) Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study. J Clin Psychiatry 66(4):444-9
95. Meador KJ, Baker GA, Browning N, Cohen MJ, Clayton-Smith J, Kalayjian LA, Kanner A (2005) Antipsychotic drugs: a prospective comparative study. J Clin Psychiatry 66:444-449
96. Meador KJ, Penovich P (2008) What is the risk of orofacial clefts from lamotrigine exposure during pregnancy? Neurology 71(10):706-707
97. Meador KJ, Baker GA, Browning N, Cohen MJ, ClaytonSmith J, Kalayjian LA, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW, NEAD Study Group (2011) Foetal antiepileptic drug exposure and verbal versus non-verbal abilities at three years of age. Brain 134:396-404
98. Mendhekar DN, Sharma JB, Srivastava PK (2003) Clozapine and pregnancy [letter]. J Clin Psychiatry 64:850
99. Mendhekar DN, Sunder KR, Andrade C (2006a) Aripiprazole use in a pregnant schizoaffective woman. Bipolar Disord 8:299-300
100. Mendhekar DN, Sharma JB, Srilakshmi P (2006b) Use of aripiprazole during late pregnancy in a woman with psychotic illness [letter]. Ann Pharmacother 40:575
101. Merlob P, Mor N, Litwin A (1992) Transient hepatic dysfunction in an infant of an epileptic mother treated with carbamazepine during pregnancy and breastfeeding. Ann Pharmacother 26:1563-1565
102. Mervak B, Collins J, Valenstein M (2008) Case report of aripiprazole usage during pregnancy. Arch Womens Ment Health 11(3):249-250
103. Milkovich L, van den Berg BJ (1976) An evaluation of the teratogenicity of certain antinauseant drugs. Am J Obstet Gynecol 125:244-248
104. Misri S, Sivertz K (1991) Tricyclic drugs in pregnancy and lactation: a preliminary report. Int J Psychiatry Med 21(2):157-171
105. Mohan MS, Patole SK, Whitehall JS (2000) Severe hypothermia in a neonate following antenatal exposure to haloperidol [letter]. J Paediatr Child Health 36:412
106. Morrow J, Russell A, Guthrie E, Parsons L, Robertson I, Waddell R, Irwin B, McGivern RC, Morrison PJ, Craig J (2006) Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 77(2):193-198
107. Morrow JI, Hunt SJ, Russell AJ, Smithson WH, Parsons L, Robertson I, Waddell R, Irwin B, Morrison PJ, Craig JJ (2009) Folic acid use and major congenital malformations in offspring of women with epilepsy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 80(5):506-511
108. Newport DJ, Pennell PB, Calamaras MR, Ritchie JC, Newman M, Knight B, Viguera AC, Liporace J, Stowe ZN (2008) Lamotrigine in breast milk and nursing infants: determination of exposure. Pediatrics 122(1):223-231
109. Nguyen T, Teoh S, Hackett LP, Ilett K (2011) Placental transfer of aripiprazole. Aust N Z J Psychiatry 45(6):500-501
110. Nora JJ, Nora AH, Toews WH (1974) Lithium, Ebstein's anomaly and other congenital heart defects. Lancet 2:594-595
111. Nulman I, Rovet J, Stewart DE, Wolpin J, Gardner HA, Theis JG, Kulin N, Koren G (1997) Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med 336(4):258-262
112. O'Brien Bar-Oz B, Einarson T, Einarson A (2008) Paroxetine and congenital malformations: meta-analysis and consideration of potential confounding factors. Clin Ther 29(5):918-926
113. O'Collins K, Comer JB (2003) Maternal haloperidol therapy associated with dyskinesia in a newborn. Am J Health Syst Pharm 60:2253-2255
114. Oberlander TF, Warburton W, Misri S, Riggs W, Aghajanian J, Hertzman C (2008) Major congenital malformations following prenatal exposure to serotonin reuptake inhibitors and benzodiazepines using population-based health data. Birth Defects Res B Dev Repord Toxicol 83(1):68-76
115. Pace A, D'Agostino F (2003) Quetiapine in pregnancy: a case report [in Italian]. Giorn It Ost Ginecol 25:381-385
116. Palac S, Meador KJ (2011) Antiepileptic drugs and neurodevelopment: an update. Curr Neurol Neurosci Rep 11(4):423-427, Review
117. Pariante CM, Seneviratne G, Howard L (2011) Should we stop using tricyclic antidepressants in pregnancy? Psychol Med 41(1):15-17, Review
118. Pastuszak A, Schick-Boschetto B, Zuber C (1993) Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac). JAMA 269:2246-2248
119. Patil AS, Kuller JA, Rhee EH (2011) Antidepressants in pregnancy: a review of commonly prescribed medications. Obstet Gynecol Surv 66(12):777-787
120. Pawluski JL (2011). Perinatal Selective Serotonin Reuptake Inhibitor Exposure: Impact on Brain Development and Neural Plasticity. Neuroendocrinology. (Epub ahead of print)
121. Pearlstein T (2008) Perinatal depression: treatment options and dilemmas. J Psychiatry Neurosci 33(4):302-318, Review
122. Peitl MV, Petric D, Peitl V (2010) Ziprasidone as possible cause of cleft palate in the newborn. Psychiatr Danub 22(11):117-119
123. Pohl-Guimaraes F, Krahe TE, Medina AE (2011) Early valproic acid exposure alters functional organization in the primary visual cortex. Exp Neurol 228(1):138-148
124. Rampono J, Simmer K, Ilett KF, Hackett LP, Doherty DA, Elliot R, Kok CH, Coenen A, Forman T (2009) Placental transfer of SSRI and SNRI antidepressants and effects on the neonate. Pharmacopsychiatry 42(3):95-100
125. Rawlings WJ, Ferguson R, Madison TG (1963) Phenmetrazine and trifluoperazine [letter]. Med J Aust 1:370
126. Reis M, Källén B (2010) Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data. Psychol Med 40(10):1723-1733
127. Rochow N, Küster H, Bandt C, Hoffmann U, Fusch C (2008) Case 1: unexpected muscular hypotonia and need for mechanical ventilation in a preterm infant. Prolonged effect of diazepam. Acta Paediatr 97(12):1602-1603
128. Rosenberg L, Mitchell AA, Parsells JL, Pashayan H, Louik C, Shapiro S (1983) Lack of relation of oral clefts to diazepam use during pregnancy. N Engl J Med 309(21):1282-1285
129. Rumeau-Roquette C, Goujard J, Huel G (1975) Possible teratogenic effect of phenothiazines in humans beings. Teratology 15:57-64
130. Safra MJ, Oakeley GP (1975) Association between cleft lip with or without cleft palate and prenatal exposure to diazepam. Lancet 2(7933):478-480
131. Safra MJ, Oakley GP Jr (1976a) Valium: an oral cleft teratogen? Cleft Palate J 13:198-200
132. Safra MJ, Oakley GP Jr (1976b) Association between cleft lip with or without cleft palate and prenatal exposure to diazepam. Lancet 2(7933):478-480
133. Sanz EJ, De-las-Cuevas C, Kiuru A, Bate A, Edwards R (2005) Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis. Lancet 365(9458):482-487
134. Sawada Feldman H, Lyons Jones K, Lindsay S, Slymen D, Klonoff-Cohen H, Kao K, Rao S, Scokel PW, Jones WN (1962) Infant jaundice after phenothiazine drugs for labor: an enigma. Obstet Gynecol 20:124-127
135. Schou M (1976a) Lithium treatment during pregnancy, delivery, and lactation: an update. J Clin Psychiatry 51:410-413
136. Schou M (1976b) What happened later to the lithium babies? A follow-up study of children born without malformations. Acta Psychiatr Scand 54:193-1927
137. Seay PH, Field WE (1968) Toxicological studies on haloperidol. Int J Neuropsychiatry 3(suppl):1-4
138. Sexson WR, Barak Y (1989) Withdrawal emergent syndrome in an infant associated with maternal haloperidol therapy. J Perinatol 9:170-172
139. Shallcross R, Bromley RL, Irwin B, Bonnett LJ, Morrow J, Baker GA, Liverpool Manchester Neurodevelopment Group, UK Epilepsy and Pregnancy Register (2011) Child development following in utero exposure: levetiracetam vs sodium valproate. Neurology 76(4):383-389
140. Simon GE, Cunningham ML, Davis RL (2002) Outcomes of prenatal antidepressant exposure. Am J Psychiatry 159(12):2055-2061
141. Sivojelezova A, Shuhaiber S, Sarkissian L (2005) Citalopram use in pregnancy: prospective comparative evaluation of pregnancy and fetal outcome. Am J Obstet Gynecol 193:2004-2009
142. Slone D, Siskind V, Heinonen OP, Monson RR, Kauffman DW, Shapiro S (1977a) Antenatal exposure to phenothiazines in relation to congenital malformations, perinatal mortality rate, birth weight, and intelligence quotient score. Am J Obstet Gynecol 128:486-488
143. Slone D, Siskind V, Heinonen OP, Monson RR, Kauffman DW, Shapiro S (1977b) Antenatal exposure to phenothiazines in relation to congenital malformations, perinatal mortality rate, birth weight, and intelligence quotient score. Am J Obstet Gynecol 128:486-488
144. Soyka LF, Bigelow SW. Drug metabolizing enzymes and their activity in the human fetus. In: Spryropoulou AC, Zrvas IM, Soldatos CR. Hip dysplasia following a case of olanzapine exposed pregnancy: a questionable association. Arch Womens Ment Health. 9:219-222, 2006.
145. Stahl MM, Lindquist M, Pettersson M (1997) Withdrawal reactions with selective serotonin re-uptake inhibitors as reported to the WHO system. Eur J Clin Pharmacol 53(3-4):163-169
146. Stern L (ed) (1984) Drug use in pregnancy. Adis Health Sciences Press, Sydney, pp 17-44
147. Steiner M, Yonkers KA, Erikson E (2000) Mood disorders in women. Martin Dunitz, London, pp 295-313
148. Stiskal JA, Kulin N, Koren G, Ho T, Ito S (2001) Neonatal paroxetine withdrawal syndrome. Arch Dis Child Fetal Neonatal Ed 84(2):F134-F135
149. Stoner SC, Sommi RW Jr, Marken PA, Anya L, Vaughn J (1997) Clozapine use in two full-term pregnancies [letter]. J Clin Psychiatry 58:364-365
150. Szigethy EM, Wisner KL (2000) Psychopharmacological treatment of mood and anxiety disorders during pregnancy. In: Steiner M, Yonkers KA, Eriksson E (eds) Mood disorders in women. Martin Dunitz Ltd, London, pp 295-313
151. Taylor TM, O'Toole MS, Ohlsen RI, Walters J, Pilousley CS (2003) Safety of quetiapine during pregnancy [letter]. Am J Psychiatry 160:588-589
152. Tekin M, Ellison J (2000) Oromandibular-limb hypogenesis spectrum and maternal lithium use. Clin Dysmorphol 9:139-141
153. Tényi T, Trixler M (1998) Clozapine in the treatment of pregnant schizophrenic women [in Hungarian]. Psychiatr Danub 10:15-18
154. Tényi T, Trixler M, Kerestes Z (2002) Quetiapine and pregnancy [letter]. Am J Psychiatry 159:674
155. Titze K, Koch S, Helge H, Lehmkuhl U, Rauh H, Steinhausen HC (2008) Prenatal and family risks of children born to mothers with epilepsy: effects on cognitive development. Dev Med Child Neurol 50(2):117-122
156. Trenque T, Piednoir D, Frances C, Millart H, Germain ML (2002) Reports of withdrawal syndrome with the use of SSRIs: a case/non-case study in the French pharmacovigilance. Pharmacoepidemiol Drug Saf 11(4):281-283
157. Twaites BR, Wilton LV, Shakir SAW (2007) The safety of quetiapine: results of a post-marketing surveillance study on 1728 patients in England. J Psychopharmacol 21:392-399,
158. database. Pharmacoepidemiol Drug Saf. 11(4):281-283, 2002
159. Vajda FJ, Eadie MJ (2005) Maternal valproate dosage and foetal malformations. Acta Neurol Scand 112(3):137-143
160. Vajda FJ, Graham JE, Hitchcock AA, O'Brien TJ, Lander CM, Eadie MJ (2010) Is lamotrigine a significant human teratogen? Observations from the Australian Pregnancy Register. Seizure 19(9):558-561
161. Van Allen MI, Fraser FC, Dallaire L, Allanson J, McLeod DR, Andermann E, Friedman JM (1993) Recommendations on the use of folic acid supplementation to prevent the recurrence of neural tube defects. Clinical Teratology Committee, Canadian College of Medical Geneticists. CMAJ 149(9):1239-1243
162. van der Lugt NM, van de Maat JS, van Kamp IL, van der Klein Knoppert EA, Hovens JG, Walther FJ (2012) Fetal, neonatal and developmental outcomes of lithium-exposed pregnancies. Early Hum Dev 88(6):375-378
163. Van Waes A, Van de Velde E (1969) Safety evaluation of haloperidol in the treatment of hyperemesis gravidarum. J Clin Pharmacol 9:224-227
164. Vemuri MP, Rasgon NL (2007) A case of olanzapine-induced gestational diabetes mellitus in the absence of weight gain [letter]. J Clin Psychiatry 68:1989
165. Viguera AC, Tondo L, Koukopoulos AE, Reginaldi D, Lepri B, Baldessarini RJ (2011) Episodes of mood disorders in 2,252 pregnancies and postpartum periods. Am J Psychiatry 168(11):1179-1185
166. Watanabe N, Kasahara M, Sugibayashi R, Nakamura T, Nakajima K, Watanabe O, Murashima A (2011) Perinatal use of aripiprazole: a case report. J Clin Psychopharmacol 31(3):377-379
167. Wadelius M, Darj E, Frenne G, Rane A (1997) Induction fo CYP2D6 in pregnancy. Clin Pharmacol Ther 62:400-407
168. Waldman MD, Safferman A (1993) Pregnancy and clozapine [letter]. Am J Psychiatry 150:168-169
169. Weinstein MR (1976) The international register of lithium babies. Drug Inf J 50:81-86
170. Weinstock L, Cohen LS, Bailey JW, Blatman R, Rosenbaum JF (2001) Obstetrical and neonatal outcome following clonazepam use during pregnancy: a case series. Psychother Psychosom 70(3):158-162
171. Wen SW, Walker M (2004) Risk of fetal exposure to tricyclic antidepressants. J Obstet Gynaecol Can 26(10):887-892
172. Wen SW, Yang Q, Garner P (2006) Selective serotonin reuptake inhibitors and adverse pregnancy outcomes. Am J Obstet Gynecol 194:961-966
173. Wide K, Winbladh B, Källén B (2004) Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation-wide, population-based register study. Acta Paediatr 93(2):174-176
174. Wikner BN, Källén B (2011) Are hypnotic benzodiazepine receptor agonists teratogenic in humans? J Clin Psychopharmacol 31(3):356-359
175. Wikner BN, Stiller CO, Bergman U, Asker C, Källén B (2007) Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: neonatal outcome and congenital malformations. Pharmacoepidemiol Drug Saf 16(11):1203-1210
176. Wilson KL, Zelig CM, Harvey JP, Cunningham BS, Dolinsky BM, Napolitano PG (2011) Persistent pulmonary hypertension of the newborn is associated with mode of delivery and not with maternal use of selective serotonin reuptake inhibitors. Am J Perinatol 28(1):19-24
177. Wilton LV, Pearce GL, Martin RM, Mackay FJ, Mann RD (1998) The outcomes of pregnancy in women exposed to newly marketed drugs in general practice in England. Br J Obstet Gynaecol 105(8):882-889
178. Wogelius P, Norgaard M, Gislum M et al (2006) Maternal use of selective serotonin reuptake inhibitors and risk of congenital malformations. Epidemiology 17:701-7044
179. Wurst KE, Poole C, Ephross SA, Olshan AF (2010) First trimester paroxetine use and the prevalence of congenital, specifically cardiac, defects: a meta-analysis of epidemiological studies. Birth Defects Res A Clin Mol Teratol 88(3):159-170
180. Wyszynski DF, Nambisan M, Surve T, Alsdorf RM, Smith CR, Holmes LB, Antiepileptic Drug Pregnancy Registry (2005) Increased rate of major malformations in offspring exposed to valproate during pregnancy. Neurology 64(6):961-965
181. Yeshayahu Y (2007) The use of olanzapine in pregnancy and congenital cardiac and musculoskeletal abnormalities [letter]. Am J Psychiatry 164:1759-1769
182. Yogev Y, Bem-Haroush A, Kaplan B (2002) Maternal clozapine treatment and decreased fetal hearth rate variability. Int J Gynaecol Obstet 79:259-260
183. Yonkers KA, Little BB, March D (1998) Lithium during pregnancy: drug effects and therapeutic implications. CNS Drugs 4:261-269
184. Zajecka J, Tracy KA, Mitchell S (1997) Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review. J Clin Psychiatry 58(7):291-297